Triluma Cream Hydroquinone USP + Tretinoin 0.05%

TRI-LUMA Cream is a combination of fluocinolone acetonide (a corticosteroid), hydroquinone (a melanin synthesis inhibitor), and tretinoin (a retinoid) that works synergistically to treat facial melasma, and its use is limited to short-term therapy of up to 8 weeks.

Benefits

77% of subjects experienced complete or near-complete clearing of facial melasma by week 8, and it helps reduce the appearance of dark spots associated with melasma.

Key Ingredients

Hydroquinone 4% w/w, tretinoin 0.05% w/w, and fluocinolone acetonide 0.01% w/w.

Targeted Concerns

severe melasma

Suitable For

all skin types

How to Use

Apply a thin film to the affected area once daily, at least 30 minutes before bedtime, and during the day use sunscreen (SPF 30 or higher) and avoid sun exposure.